All
New acne drug battles bacterial resistance
February 2nd 2002Chicago - A new acne drug under development shows promise of efficacyand does not produce resistance in bacteria that causes the condition. Thenews comes at a time when the bacterium P. acnes demonstrated resistanceto traditional treatment antibiotics tetracycline and erythromycin.
Novel vaccine promising in treatment of genital warts
February 1st 2002Baltimore - Phase II study results point to the potential roleof HspE7 as a safe and effective immunotherapeutic agent for the treatmentof genital warts and other HPV-related sexually transmitted diseases, KeertiV. Shah, M.D., said.
Maligned flutamide exhibits acne, AGA benefits
February 1st 2002São Paulo, Brazil - Contrary to foregoing reports of significantside effects and high cost, Denise Steiner, M.D., Ph.D., contends that theanti-androgen drug flutamide 250 mg (Euflex, Euflexin) is a safe and effectivetherapy for treating female acne and androgenetic alopecia with an overallpositive relation of cost to benefit.
Treating warts necessitates communication
February 1st 2002The treatment of warts can be a frustrating experience for both the dermatologistas well as the patient and/or patient's family. The provider needs to bewell versed in the many rules and regulations that govern the billing ofwarts (e.g., medical necessity issues, CPT and ICD-9 coding) while the patientneeds to be educated on the nature of the condition and the complexitiesassociated with the treatment arsenal.
Cosmetic Conundrums with Zoe Diana Draelos, M.D.
February 1st 2002Q. What is a 2-in-1 shampoo?A. Two-in-1 shampoo is a shampoo designed to cleanse and condition in one step. The original 2-in-1 shampoos neither conditioned well nor cleansed well, but the new varieties have taken advantage of modern silicone technology.
Chemotherapeutic skin reactions sometimes misdiagnosed
February 1st 2002Chicago - One of the important tasks a dermatologist undertakes when assessing a cutaneous reaction to chemotherapy agents is to make sure the presenting condition is not caused by another drug or disorder, Claudia Hernandez, M.D., said.
Daptomycin impressive against dual staph, strep skin infections
February 1st 2002Chicago - Daptomycin (Cidecin), a novel lipopeptide antibiotic, showed a trend toward an improved clinical response compared to current standard therapy in the treatment of complicated skin and soft tissue (cSST) infections caused by dual infection with